Day: March 27, 2020

Haldor Topsøe A/S har besluttet at udskyde Selskabets ordinære generalforsamling planlagt til den 31. marts 2020.Beslutningen er taget på baggrund af overvejelser om aktionærernes og de ansattes sundhed og sikkerhed i overensstemmelse med den opdaterede vejledning fra de danske myndigheder i relation til COVID-19, ønsket om afholdelse af en fysisk generalforsamling efter udrulningen af Selskabets medarbejderaktieprogram (ESP) og at give bestyrelsen tid til at vurdere de økonomiske konsekvenser af den nuværende COVID-19-relaterede markedsuro på Selskabets finansielle position særligt i relation til bestyrelsens forslag om udbetaling af udbytte til Selskabets aktionærer. Indtil videre betyder dette, at bestyrelsen trækker det tidligere kommunikerede forslag om udbetaling af udbytte til Selskabets aktionærer tilbage.Haldor Topsøe A/S vil...

Over the twelve months of 2019, the turnover of Panevezio statybos trestas AB was 108.464 mln. Euros. In 2019, the net profit of the Company amounted to 0.59 mln. Euros. The revenue of Panevezio statybos trestas AB increased by 14 per cents over the year 2019.Over the same period, the total consolidated revenue of Panevezio statybos trestas AB Group was 110.466 mln. Euros, that is by 5 per cents higher compared to the year 2018 when the revenue of the Group had been 104.861 mln. Euros. The net profit of the Group amounted to 0.821 mln. Euros in 2019, whereas in 2018, the loss of the Group was 4.307 mln. Euros.More information:Dalius GeseviciusManaging DirectorTel.: (+370 45) 505 503AttachmentsPST_COMPANI_Preliminary_2019_ENPST_GRUOP_Preliminary_2019_EN

AB „Panevėžio statybos trestas“ pardavimai per 2019 metų dvylika mėnesių sudarė 108,464 mln. eurų. 2019 metais bendrovė uždirbo  0,59 mln. eurų grynojo pelno. 2019 metais AB „Panevėžio statybos trestas“ pajamos išaugo 14 procentų.Per tą patį laikotarpį AB „PST“ įmonių grupės bendros konsoliduotos pajamos sudarė 110,466 mln. eurų. Tai yra 5 procentais daugiau nei 2018 metais, kai Grupės pajamos buvo 104,861 mln. eurų. 2019 metų Grupė uždirbo 0,821 mln. eurų grynojo pelno, 2018 metais Grupės  nuostolis siekė 4,307 mln. eurų.Daugiau informacijos:Generalinis direktoriusDalius GesevičiusTel.: 8 45 505 503PriedaiPST_SOLO_Preliminarūs_2019PST_GRUPE_Preliminarūs_2019

VANCOUVER, British Columbia, March 27, 2020 (GLOBE NEWSWIRE) — TELUS today announced a $500,000 donation to the Vancouver Prostate Centre (VPC), Vancouver General Hospital (VGH) and University of British Columbia (UBC) Hospital Foundation to assist in the search for therapeutic antiviral treatments for COVID-19. Led by Professor Art Cherkasov, VPC and UBC scientists have joined forces with experts around the world including collaborations with Cambridge in the UK, Memorial Sloan-Kettering in New York, University of North Carolina Pharma Science, and Enamine, the biggest small molecule supplier in the world, in the Ukraine. This Vancouver-led team brings together some of the best talent in the world in medicinal chemistry and virology.‘‘We are encouraged by the incredible expertise of the researchers that make up this global consortium...

VANCOUVER, Colombie-Britannique, 27 mars 2020 (GLOBE NEWSWIRE) — TELUS a annoncé aujourd’hui qu’elle fera un don de 500 000 $ au Vancouver Prostate Centre (VPC) et à la fondation de l’hôpital général de Vancouver (VGH) et de l’hôpital de l’Université de la Colombie-Britannique (UBC) pour contribuer à financer la recherche de traitements antiviraux contre la COVID-19. Sous la direction du professeur Art Cherkasov, les scientifiques du VPH, VGH et UBC ont joint les rangs d’experts du monde entier. Ils collaborent notamment avec l’Université de Cambridge au Royaume-Uni, le Memorial Sloan-Kettering à New York, le programme de sciences pharmaceutiques de l’Université de Caroline du Nord, et Enamine, le plus grand fournisseur de petites molécules au monde, en Ukraine. Cette équipe, qui est dirigée à partir de Vancouver, rassemble certains...

Vilnius, March 27, 2020 (GLOBE NEWSWIRE) — Medicinos Bankas UAB would like to inform you that the meeting of the Supervisory Board of the bank of 26 March 2020 elected the current members of the Board, i.e. Dalia Klišauskienė, Igor Kovalčuk and Marius Arlauskas, for a new term of four years. Aleksėjus Tonkich who has been working for the bank since September 2008 and is currently the Director of the Accounting and Reporting Department was elected to be the fourth member of the Board. He will take up his duties as a member of the Board as soon as the Bank of Lithuania gives him permission to act as a manager of the bank.The Supervisory Board of the bank elected the members of the Board at the end of the term provided for in the Statute of the bank.For more information please call : +370 610 21691 or via e-mail: media@medbank.lt ;

Vilnius, March 27, 2020 (GLOBE NEWSWIRE) — UAB Medicinos bankas informuoja, kad 2020 m. kovo 26 d. įvykusio banko stebėtojų tarybos posėdyje naujai ketverių metų kadencijai į banko valdybą išrinkti esami banko valdybos nariai Dalia Klišauskienė, Igor Kovalčuk ir Marius Arlauskas. Ketvirtuoju  valdybos nariu yra išrinktas Aleksėjus Tonkich kuris banke dirba nuo 2008 m. rugsėjo ir šiuo metu eina banko apskaitos ir ataskaitų departamento direktoriaus pareigas. Aleksejus Tonkich pradės eiti valdybos nario pareigas kai bus gautas Lietuvos banko leidimas tapti banko vadovu.Banko stebėtojų taryba valdybą išrinko pasibaigus banko įstatuose nustatytai ketverių metų valdybos kadencijai.For more information please call : +370 610 21691 or via e-mail: media@medbank.lt ;

Copenhagen, March 27, 2020 (GLOBE NEWSWIRE) —Bestyrelsen har i dag behandlet og vedtaget årsrapporten for Investeringsforeningen BankInvestÅrsrapport med beretning, regnskab og nøgletal for den enkelte forening er vedlagt og vil ligeledes kunne rekvireres hos investeringsforvaltningsselskabet/forvalteren BI Management A/S eller downloades via foreningernes hjemmeside www.bankinvest.dk.Årsrapporten vil blive fremlagt til godkendelse på foreningens ordinære generalforsamling.Spørgsmål til årsrapporterne kan rettes til investeringsforvaltningsselskabets/forvalterens vicedirektør Henrik Granlund på tlf. nr. 77 30 90 00.Med venlig hilsenInvesteringsforeningen BankInvestOle Jørgensen                     Ingelise Bogason                Niels HeeringBestyrelsesformand              Næstformand                     NæstformandVedhæftet filÅrsrapport...

STOCKHOLM, SWEDEN – 27 March 2020. Karolinska Development (Nasdaq Stockholm: KDEV) announces today that the company has made an investment in Svenska Vaccinfabriken Produktion AB (“SVF”). SVF develops therapeutic proteins and DNA vaccines against hepatitis B, hepatitis D and other viral diseases, as well as vaccines to prevent infections of Covid-19 and potential future Coronaviruses. SVF’s innovative vaccine platform technology has been developed by researchers at the Karolinska Institute in Huddinge, Sweden. The projects are currently in the preclinical phase and the first clinical trials could potentially be initiated in 2021.As a result of the initial investment, Karolinska Development will own five percent of the shares in SVF. Further, an option agreement gives the opportunity to increase the ownership to a total of...

Due to the development in connection with the outbreak of Covid-19, Solar A/S withdraws the previously announced outlook for 2020.January, February and the first three weeks of March went exactly as planned financially. We are, however, starting to see a slight decline in revenue in some markets.We will disclose a new guidance as soon as we get an overview of the effect the outbreak will have on Solar.Our number one priority is to protect employees and business partners. Thus, we have introduced a number of initiatives to limit the risk of infection in order to ensure our business’ continuity and stability.We are currently only experiencing minor changes in deliveries from suppliers. Our strong partnerships with the suppliers mean that we have alternatives to both products and production sites, and we are doing everything we can to uphold...